TEAD:NASDAQTeads Holding Co. Analysis
Data as of 2026-08-02 - not real-time
$0.71
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Teads is trading at $0.71, well below its 20‑day ($0.81), 50‑day ($1.00) and 200‑day ($0.88) simple moving averages, indicating a bearish technical backdrop, while the RSI of 35.6 suggests the stock is approaching oversold territory. The MACD line has just crossed above its signal, generating a modest bullish histogram, but volume is on a declining trend and 30‑day volatility exceeds 100%, underscoring a highly erratic price environment. On the fundamentals side, the company reports a steep revenue decline of -7.1% YoY, negative operating (-7.1%) and profit margins (-39%), and a crippling debt‑to‑equity ratio above 1300, with net debt vastly outstripping cash. Nonetheless, the price‑to‑sales multiple sits at a scant 0.054 and price‑to‑book at 1.37, pointing to a potentially deep discount relative to peers, and the recent press release touts a 50% revenue uplift and a strategic partnership with TiVo Ads that could unlock new inventory and AI‑driven monetisation.
Given the extreme market greed sentiment (Fear & Greed Index 92.9) and a historical max drawdown of -77%, the upside potential is sizable but hinges on the company’s ability to translate its partnership and restructuring promises into sustainable cash flow while managing its massive leverage.
Given the extreme market greed sentiment (Fear & Greed Index 92.9) and a historical max drawdown of -77%, the upside potential is sizable but hinges on the company’s ability to translate its partnership and restructuring promises into sustainable cash flow while managing its massive leverage.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above the identified support of $0.68
- Negative earnings and cash flow with high leverage
- Elevated volatility and decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential revenue lift from the TiVo Ads partnership
- Deep valuation discounts (P/S ~0.05, P/B ~1.4)
- Improved sentiment reflected in the extreme greed index
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Unsustainable debt load (Debt/Equity >1300) and ongoing cash burn
- Uncertainty around profitability despite strategic initiatives
- High beta (~2.2) and historic drawdown of -77% indicating long‑run price instability
Key Metrics & Analysis
Financial Health
Revenue Growth-7.10%
Profit Margin-39.14%
P/E Ratio-1.3
ROE-190.89%
ROA-1.28%
Debt/Equity1300.15
P/B Ratio1.4
Op. Cash Flow$-26299000
Free Cash Flow$-10316250
Industry P/E15.7
Technical Analysis
TrendNeutral
RSI35.6
Support$0.68
Resistance$0.97
MA 20$0.81
MA 50$1.00
MA 200$0.88
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Target Price$1.20
Upside/Downside69.47%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.24
Volatility101.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.